Please login to the form below
Robust Review: Surrogate Endpoints
See how our client utilized Rapid Payer Response™ (RPR) to gain invaluable payer insight and understanding of the acceptability and importance of surrogate end-points for their product…In 3 Weeks not 5 Months!
Recently, a client leveraged Rapid Payer Response (RPR) to understand payer evidence requirements for studies in the adjuvant setting in oncology. In our first round of Robust Review we explore general acceptability in the therapeutic area. In the next round of Robust Review we will share how these results from RPR impacted the client’s trial design.
Download to learn more.
Downloads
Robust Review: Surrogate Endpoints
PDF File: 529.3 KB
Company Details
Market Access Transformation
Address:
51 John F Kennedy Parkway
1st Floor West
Short Hills
New jersey
07078
USA
Latest content on this profile
- Robust Review: Surrogate Endpoints
- See how our client utilized Rapid Payer Response™ (RPR) to gain invaluable payer insight and understanding of the acceptability and importance of surrogate end-points for their product…In 3 Weeks not 5 Months!
Market Access Transformation
- Robust Review: Clinical Trial Design
- See how our client utilized Rapid Payer Response™ (RPR) to gain invaluable payer insight to develop the optimal clinical trial for their product…In 3 Weeks not 5 Months!
Market Access Transformation
- Robust Review: Multi-Indication Prioritization
- See how our client leveraged Rapid Payer Response™ (RPR) to prioritize their asset's commercial opportunity across multiple indications in Acute Lymphoblastic Leukemia (ALL)… And got their Insights Report delivered in just 3 weeks!
Market Access Transformation
- Robust Review: Vetting Evidence Generation Plan
- See how our client utilized Rapid Payer Response™ (RPR) to gain invaluable payer insight into their TPP and the design of their evidence generation plan…in 3 Weeks!
Market Access Transformation
- Robust Review: Pricing & Market Access
- See how our client utilized Rapid Payer Response™ (RPR) to gain invaluable Payer insight into the Pricing and Market Access acceptability of their novel product within 3 Weeks.
Market Access Transformation
- Robust Review: COVID19 Assessment
- See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)
Market Access Transformation
